)
)
Double Bond Pharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Double Bond Pharmaceutical
Access all reports
Double Bond Pharmaceutical International AB is a pharmaceutical company focused on the research, development, and commercialization of treatments for rare diseases, with a particular emphasis on oncology and infectious diseases. The company employs innovative drug delivery technologies to enhance therapeutic efficacy and safety. DBP's product portfolio includes a range of novel formulations and proprietary solutions aimed at addressing unmet medical needs in its target areas. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq First North.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
DBP
Country
🇸🇪 Sweden